NO20034497L - Somatostatin agonister - Google Patents

Somatostatin agonister

Info

Publication number: NO20034497L
Authority: NO; Norway
Prior art keywords: somatostatin agonists; somatostatin; agonists
Prior art date: 2001-04-09

Application number

NO20034497A

Other languages

English (en)

Other versions

NO20034497D0 (no

Inventor

David H Coy

Walajapet G Rajeswaran

Original Assignee

Univ Tulane

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-09

Filing date

2003-10-08

Publication date

2003-10-27

2003-10-08 Application filed by Univ Tulane filed Critical Univ Tulane

2003-10-08 Publication of NO20034497D0 publication Critical patent/NO20034497D0/no

2003-10-27 Publication of NO20034497L publication Critical patent/NO20034497L/no

Links

102000005157 Somatostatin Human genes 0.000 title 1
108010056088 Somatostatin Proteins 0.000 title 1
239000000556 agonist Substances 0.000 title 1
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
229960000553 somatostatin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Heart & Thoracic Surgery (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Reproductive Health (AREA)
Cardiology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Physical Education & Sports Medicine (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Pregnancy & Childbirth (AREA)
Orthopedic Medicine & Surgery (AREA)
Nutrition Science (AREA)

NO20034497A 2001-04-09 2003-10-08 Somatostatin agonister NO20034497L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US28252601P	2001-04-09	2001-04-09
PCT/US2002/010882 WO2002081499A2 (en)	2001-04-09	2002-04-08	Somatostatin agonists

Publications (2)

Publication Number	Publication Date
NO20034497D0 NO20034497D0 (no)	2003-10-08
NO20034497L true NO20034497L (no)	2003-10-27

Family

ID=23081905

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034497A NO20034497L (no)	2001-04-09	2003-10-08	Somatostatin agonister

Country Status (15)

Country	Link
US (2)	US7312304B2 (no)
EP (1)	EP1397150A4 (no)
JP (2)	JP2004531520A (no)
KR (1)	KR20030088494A (no)
CN (1)	CN1541102A (no)
AU (1)	AU2002256105B2 (no)
CA (1)	CA2443085A1 (no)
CZ (1)	CZ20032707A3 (no)
HU (1)	HUP0303727A2 (no)
IL (1)	IL158051A0 (no)
MX (1)	MXPA03009048A (no)
NO (1)	NO20034497L (no)
PL (1)	PL368941A1 (no)
RU (1)	RU2259375C2 (no)
WO (1)	WO2002081499A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2425804A1 (en) *	2000-10-20	2002-04-25	The Administrators Of The Tulane Educational Fund	Urotensin-ii agonists and antagonists
CZ299362B6 (cs)	2001-03-08	2008-07-02	The Administrators Of The Tulane Educational Fund	Antagonisté somatostatinu
WO2005052366A2 (en)	2003-11-20	2005-06-09	The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.	Portable hand pump for evacuation of fluids
US8337475B2 (en)	2004-10-12	2012-12-25	C. R. Bard, Inc.	Corporeal drainage system
CN101163505A (zh) *	2005-04-13	2008-04-16	伊拉斯谟大学鹿特丹医药中心	使用gh拮抗剂和生长抑素激动剂的治疗方法
WO2007038643A1 (en)	2005-09-26	2007-04-05	C.R. Bard, Inc.	Catheter connection systems
DK2118123T3 (en)	2007-01-31	2016-01-25	Dana Farber Cancer Inst Inc	Stabilized p53 peptides and uses thereof
KR101623985B1 (ko)	2007-03-28	2016-05-25	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	스티칭된 폴리펩티드
DK2603600T3 (da)	2010-08-13	2019-03-04	Aileron Therapeutics Inc	Peptidomimetiske makrocyklusser
BR112014009418A2 (pt)	2011-10-18	2017-04-18	Aileron Therapeutics Inc	macrociclos peptidomiméticos
HK1205454A1 (en)	2012-02-15	2015-12-18	Aileron Therapeutics, Inc.	Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN112500466B (zh)	2012-02-15	2022-05-03	艾瑞朗医疗公司	拟肽大环化合物
WO2013132505A1 (en)	2012-03-09	2013-09-12	Natco Pharma Limited	Improved process for preparation of octreotide by solution phase peptide synthesis
CN104321074B (zh) *	2012-04-12	2017-09-08	诺华股份有限公司	生长抑素类似物与11β‑羟化酶抑制剂的组合
WO2014071241A1 (en)	2012-11-01	2014-05-08	Aileron Therapeutics, Inc.	Disubstituted amino acids and methods of preparation and use thereof
JP6869720B2 (ja) *	2013-06-13	2021-05-12	アンチセンスセラピューティクスリミテッド	併用療法
CA2961258A1 (en)	2014-09-24	2016-03-31	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles and uses thereof
CA2979847A1 (en)	2015-03-20	2016-09-29	Aileron Therapeutics, Inc.	Peptidomimetic macrocycles and uses thereof
WO2025137441A1 (en) *	2023-12-22	2025-06-26	Rayzebio, Inc.	Radiopharmaceuticals targeting somatostatin receptor 2 and uses thereof
WO2025137443A1 (en) *	2023-12-22	2025-06-26	Rayzebio, Inc.	Radiopharmaceutical compositions targeting somatostatin receptors and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH679045A5 (no) *	1987-06-29	1991-12-13	Sandoz Ag
US5633263A (en) *	1989-04-26	1997-05-27	The Administrators Of The Tulane Educational Fund	Linear somatostatin analogs
JP2882679B2 (ja) *	1989-04-26	1999-04-12	ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド	線状ソマトスタチン類似体
ATE140237T1 (de) *	1989-12-08	1996-07-15	Univ Tulane	Oktapeptidanaloge von somatostatin mit threonin in position 6
US5462926A (en) *	1992-07-27	1995-10-31	Biomeasure, Inc.	Neuromedin B receptor antagonists which demonstrate selectivity
US5504069A (en) *	1993-02-11	1996-04-02	Biomeasure, Inc.	Inhibition of trauma-induced tumor growth
US5583104A (en) *	1993-12-06	1996-12-10	Mayo Foundation For Medical Research And Education	Treatment of proliferation of bile duct epithelium
GB9402767D0 (en) *	1994-02-14	1994-04-06	Sandoz Ltd	Improvements in or relating to organic compounds
US6051206A (en) *	1994-06-03	2000-04-18	Diatide, Inc	Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
RU2177006C2 (ru) *	1995-09-29	2001-12-20	Биомежер Инкорпорэйтед	Циклические пептидные аналоги соматостатина
US6355613B1 (en) *	1996-07-31	2002-03-12	Peptor Limited	Conformationally constrained backbone cyclized somatostatin analogs
AU3215597A (en)	1996-08-30	1998-03-19	Biomeasure Incorporated	Method of inhibiting fibrosis with a somatostatin agonist
US6262229B1 (en) *	1996-12-04	2001-07-17	Biomeasure Incorporated	Somatostatin antagonists
CA2274144C (en) *	1996-12-04	2004-03-30	Societe De Conseils De Recherches Et D'applications Scientifiques S.A. (A.S.)	Somatostatin antagonists
US6025372A (en) *	1997-04-04	2000-02-15	Merck & Co., Inc.	Somatostatin agonists
US6004928A (en) *	1997-05-13	1999-12-21	Biomeasure, Incorporated	Method of treating hyperlipidemia
CZ299362B6 (cs) *	2001-03-08	2008-07-02	The Administrators Of The Tulane Educational Fund	Antagonisté somatostatinu

2002
- 2002-04-08 AU AU2002256105A patent/AU2002256105B2/en not_active Expired - Fee Related
- 2002-04-08 KR KR10-2003-7013240A patent/KR20030088494A/ko not_active Ceased
- 2002-04-08 JP JP2002579485A patent/JP2004531520A/ja active Pending
- 2002-04-08 US US10/474,248 patent/US7312304B2/en not_active Expired - Lifetime
- 2002-04-08 IL IL15805102A patent/IL158051A0/xx unknown
- 2002-04-08 MX MXPA03009048A patent/MXPA03009048A/es unknown
- 2002-04-08 CZ CZ20032707A patent/CZ20032707A3/cs unknown
- 2002-04-08 WO PCT/US2002/010882 patent/WO2002081499A2/en not_active Ceased
- 2002-04-08 EP EP02725548A patent/EP1397150A4/en not_active Withdrawn
- 2002-04-08 RU RU2003132548/04A patent/RU2259375C2/ru not_active IP Right Cessation
- 2002-04-08 HU HU0303727A patent/HUP0303727A2/hu unknown
- 2002-04-08 CA CA002443085A patent/CA2443085A1/en not_active Abandoned
- 2002-04-08 CN CNA02808005XA patent/CN1541102A/zh active Pending
- 2002-04-08 PL PL02368941A patent/PL368941A1/xx not_active Application Discontinuation
2003
- 2003-10-08 NO NO20034497A patent/NO20034497L/no not_active Application Discontinuation
2007
- 2007-09-21 JP JP2007245290A patent/JP2008069160A/ja active Pending
- 2007-10-11 US US11/973,954 patent/US20080090756A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2008069160A (ja)	2008-03-27
CN1541102A (zh)	2004-10-27
US7312304B2 (en)	2007-12-25
WO2002081499A3 (en)	2003-05-08
HUP0303727A2 (hu)	2004-03-01
KR20030088494A (ko)	2003-11-19
US20040171530A1 (en)	2004-09-02
EP1397150A2 (en)	2004-03-17
NO20034497D0 (no)	2003-10-08
WO2002081499A2 (en)	2002-10-17
PL368941A1 (en)	2005-04-04
MXPA03009048A (es)	2004-02-12
JP2004531520A (ja)	2004-10-14
CZ20032707A3 (cs)	2004-01-14
EP1397150A4 (en)	2005-01-26
CA2443085A1 (en)	2002-10-17
RU2259375C2 (ru)	2005-08-27
AU2002256105B2 (en)	2006-04-06
IL158051A0 (en)	2004-03-28
US20080090756A1 (en)	2008-04-17
RU2003132548A (ru)	2005-02-27

Publication	Publication Date	Title
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
DE60227371D1 (de)	2008-08-14	Schnellverbinder
DE60227853D1 (de)	2008-09-04	Substituierte Pyridinylamine
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
DE60230521D1 (de)	2009-02-05	Fluiddruckreduzierventil
DE60221583D1 (de)	2007-09-13	Kompressorantreibsystem
EP1395727A4 (en)	2005-05-11	ROCKER GARAGE DOOR
DE50214313D1 (de)	2010-05-12	Koaxialmagentventil
DE60227839D1 (de)	2008-09-04	Martensitische nanoverbundstähle
NO20034497D0 (no)	2003-10-08	Somatostatin agonister
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
DE60222752D1 (de)	2007-11-15	Unterwasserkommunikationsssystem
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
DE60233205D1 (de)	2009-09-17	Albtonpunkten
DE50208372D1 (de)	2006-11-23	Schrankaufhängevorrichtung
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE60215160D1 (de)	2006-11-16	Starterrückspulschutzhaube
DE60233454D1 (de)	2009-10-08	Wirbelstromprüfsonde
ATE394114T1 (de)	2008-05-15	Somatostatin-antagonisten
DK1406858T3 (da)	2009-11-23	Substituerede 4-aminocyklohexanoler
DE50201862D1 (de)	2005-01-27	Messwandler
DE50214673D1 (de)	2010-11-04	Schnittstelle
DK1451167T3 (da)	2006-07-03	Phenylalkyner
DE60228031D1 (de)	2008-09-18	Tonerrecyclisierungsentwickungsverfahren
DE50202088D1 (de)	2005-03-03	Garmodulsystem

Legal Events

Date	Code	Title	Description
2006-11-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application